160 related articles for article (PubMed ID: 21674277)
1. The role of RhoC in the proliferation and apoptosis of hepatocellular carcinoma cells.
Xie S; Zhu M; Lv G; Zhang Q; Wang G
Med Oncol; 2012 Sep; 29(3):1802-9. PubMed ID: 21674277
[TBL] [Abstract][Full Text] [Related]
2. [Effect of RhoC on hepatocellular carcinoma cell growth and related molecular mechanisms].
Xie SL; Zhu MG; Lü GY; Wang GY
Zhonghua Zhong Liu Za Zhi; 2011 Apr; 33(4):270-5. PubMed ID: 21575497
[TBL] [Abstract][Full Text] [Related]
3. Overexpression of Ras homologous C (RhoC) induces malignant transformation of hepatocytes in vitro and in nude mouse xenografts.
Xie S; Zhu M; Lv G; Geng Y; Chen G; Ma J; Wang G
PLoS One; 2013; 8(1):e54493. PubMed ID: 23382905
[TBL] [Abstract][Full Text] [Related]
4. [miR-455 Inhibits HepG2 Cell Proliferation and Promotes Apoptosis by Targeting RhoC].
Xie SL; Wang M; Du XH; Zhao ZW; Lv GY
Mol Biol (Mosk); 2020; 54(1):69-77. PubMed ID: 32163390
[TBL] [Abstract][Full Text] [Related]
5. Effects of Ras homolog gene family, member C gene silencing combined with rapamycin on hepatocellular carcinoma cell growth.
Xie SL; Zhu MG; Chen GF; Wang GY; Lv GY
Mol Med Rep; 2015 Oct; 12(4):5077-85. PubMed ID: 26165487
[TBL] [Abstract][Full Text] [Related]
6. [Trametenolic acid inhibits migration and invasion of hepatocellular carcinoma HepG2.2.15 cells via RhoC/ROCK1 pathway].
Wan YL; Wang JZ; Yuan Y; Ye WY; Li HL; Zhang XL; Zhang HQ; Li LE
Zhongguo Zhong Yao Za Zhi; 2024 Jan; 49(1):185-196. PubMed ID: 38403351
[TBL] [Abstract][Full Text] [Related]
7. RhoA and RhoC -siRNA inhibit the proliferation and invasiveness activity of human gastric carcinoma by Rho/PI3K/Akt pathway.
Sun HW; Tong SL; He J; Wang Q; Zou L; Ma SJ; Tan HY; Luo JF; Wu HX
World J Gastroenterol; 2007 Jul; 13(25):3517-22. PubMed ID: 17659701
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of invasion and metastasis of hepatocellular carcinoma cells via targeting RhoC in vitro and in vivo.
Wang W; Wu F; Fang F; Tao Y; Yang L
Clin Cancer Res; 2008 Nov; 14(21):6804-12. PubMed ID: 18980974
[TBL] [Abstract][Full Text] [Related]
9. The role of RhoC in ovarian epithelial carcinoma: a marker for carcinogenesis, progression, prognosis, and target therapy.
Zhao Y; Zheng HC; Chen S; Gou WF; Xiao LJ; Niu ZF
Gynecol Oncol; 2013 Sep; 130(3):570-8. PubMed ID: 23764197
[TBL] [Abstract][Full Text] [Related]
10. Genomic analysis reveals RhoC as a potential marker in hepatocellular carcinoma with poor prognosis.
Wang W; Yang LY; Huang GW; Lu WQ; Yang ZL; Yang JQ; Liu HL
Br J Cancer; 2004 Jun; 90(12):2349-55. PubMed ID: 15150600
[TBL] [Abstract][Full Text] [Related]
11. Expression and significance of RhoC gene in hepatocellular carcinoma.
Wang W; Yang LY; Yang ZL; Huang GW; Lu WQ
World J Gastroenterol; 2003 Sep; 9(9):1950-3. PubMed ID: 12970882
[TBL] [Abstract][Full Text] [Related]
12. [Overexpression of the RhoC gene correlates with invasion and metastasis of hepatocellular carcinoma].
Wang W; Yang LY; Huang GW; Yang ZL; Lu WQ; Peng JX; Yang JQ
Zhonghua Zhong Liu Za Zhi; 2004 May; 26(5):279-82. PubMed ID: 15312362
[TBL] [Abstract][Full Text] [Related]
13. CD109 Mediates Cell Survival in Hepatocellular Carcinoma Cells.
Zong G; Xu Z; Zhang S; Shen Y; Qiu H; Zhu G; He S; Tao T; Chen X
Dig Dis Sci; 2016 Aug; 61(8):2303-2314. PubMed ID: 27074923
[TBL] [Abstract][Full Text] [Related]
14. A novel all-trans retinoic acid derivative 4-amino‑2‑trifluoromethyl-phenyl retinate inhibits the proliferation of human hepatocellular carcinoma HepG2 cells by inducing G0/G1 cell cycle arrest and apoptosis via upregulation of p53 and ASPP1 and downregulation of iASPP.
Liu H; Chen F; Zhang L; Zhou Q; Gui S; Wang Y
Oncol Rep; 2016 Jul; 36(1):333-41. PubMed ID: 27177208
[TBL] [Abstract][Full Text] [Related]
15. FAM9C plays an anti-apoptotic role through activation of the PI3K/Akt pathway in human hepatocellular carcinoma.
Zhou JD; Shen F; Ji JS; Zheng K; Huang M; Wu JC
Oncol Rep; 2013 Sep; 30(3):1275-84. PubMed ID: 23836295
[TBL] [Abstract][Full Text] [Related]
16. Elevated expression of autocrine motility factor receptor correlates with overexpression of RhoC and indicates poor prognosis in hepatocellular carcinoma.
Wang W; Yang LY; Yang ZL; Peng JX; Yang JQ
Dig Dis Sci; 2007 Mar; 52(3):770-5. PubMed ID: 17265125
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of fatty acid synthase (FASN) affects the proliferation and apoptosis of HepG2 hepatoma carcinoma cells via the β-catenin/C-myc signaling pathway.
Zhang W; Huang J; Tang Y; Yang Y; Hu H
Ann Hepatol; 2020; 19(4):411-416. PubMed ID: 32536483
[TBL] [Abstract][Full Text] [Related]
18. Hint1 suppresses migration and invasion of hepatocellular carcinoma cells in vitro by modulating girdin activity.
Wu XS; Bao TH; Ke Y; Sun DY; Shi ZT; Tang HR; Wang L
Tumour Biol; 2016 Nov; 37(11):14711-14719. PubMed ID: 27623945
[TBL] [Abstract][Full Text] [Related]
19. [Expression of RhoC protein in human primary hepatocellular carcinoma and its clinical significance].
Cai XJ; Xu GG; Shen B
Zhejiang Da Xue Xue Bao Yi Xue Ban; 2006 Jul; 35(4):394-6. PubMed ID: 16924703
[TBL] [Abstract][Full Text] [Related]
20. The effect of RhoC siRNA on the invasiveness and proliferation of human cervical cancer cell line SiHa cells.
He X; Qian Y; Cai H; Wang Z
J Huazhong Univ Sci Technolog Med Sci; 2008 Dec; 28(6):665-9. PubMed ID: 19107362
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
